Research programme: siRNA therapeutics - Aposense
Alternative Names: Research programme: siRNA therapeutics-Aposense; siRNA therapeutics - AposenseLatest Information Update: 06 May 2024
At a glance
- Originator Aposense
- Developer Aposense; biOasis Technologies
- Class Neuroprotectants; Small interfering RNA
- Mechanism of Action RNA interference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Neurological disorders